The Latest Psychedelics Articles from Streetwise Reports

Biotech at Good Entry Point for Investors, Analyst Says

Research Report
The company, focused on psychedelic-assisted psychotherapies to better treat addiction, is worth more than the CA$10 million the market is valuing it at, noted a Stifel report.
Tags:  Psychedelics

Showing Results: 1 to 1 of 1